Navigation Links
Rising Australian biotech stars set to connect on the world stage

Two of Australias leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the countrys burgeoning biopharmaceutical industry.

Antisense Therapeutics Ltd (ASX code: ANP) Research Director Dr Christopher Wraight and DendriMed Research Director Dr Raisa Monteiro have been selected as joint winners of the 2008 Advancing BioBusiness Award, which aims to expand vital global connections for Australian science and foster more international business for local life sciences companies.

They will attend the worlds largest biotechnology meeting, the Biotechnology Industry Organisation (BIO) international convention in Boston in May, which attracts over 22,000 visitors.

A tailored program of meetings will also be scheduled with leading American organisations and individuals including venture capital firms, research institutes, biotechnology entrepreneurs and biopharmaceutical companies. This will help build valuable international networks, knowledge and collaborations that will benefit their business and the Australian industry.

The Advancing BioBusiness Award is an innovative scheme by Merck Sharp & Dohme and Advance, a dynamic, diverse global community of Australian professionals overseas committed to advancing Australia and Australians.

Senator Kim Carr, Minister for Innovation, Industry, Science and Research, said:

"The Advancing BioBusiness Award complements the Rudd Government's policy of promoting innovation and commercialisation in the biotechnology and pharmaceutical sector, encouraging closer links between Australian biotech and global pharmaceutical companies, and helping Australian biotechs access global supply chains."

Dr Phil Kearney, Merck Sharp & Dohmes manager for external scientific affairs, said Australia is recognised for its excellence in medical research and its vigorous and creative biopharmaceutical industry. However the number of drug development projects which reach advanced clinical development is only a quarter of what would be predicted on the basis of our output in scientific literature.

By immersing two of our top biopharmaceutical people in successful commercial research centres in the United States, and providing them with opportunities to share their learning back at home, we aim to build a stronger Australian capability to win in this highly competitive global knowledge market, he said.


Contact: Jackie Crossman
Research Australia

Related medicine news :

1. New HIV diagnoses rising in New York City among young men who have sex with men
2. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
3. Disabilities Rising Among Workers; Need for Employer-Driven Disability Awareness, Support Efforts Also Increases
4. Spectrum of Eating Disorders - from Anorexia to Obesity - are Cause for Rising Concern among K-12 Students and Educators
5. Obesity Driving Rising U.S. Health Costs
6. Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward Americas Health Care Crisis
7. Asymptomatic peripheral artery disease prevalence is rising
8. Independent Review Organizations Poised to Help Reduce Rising Healthcare Cost
9. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
10. Surprising New Research Indicates that Significant Numbers of Children as Young as 11 are Engaging in Sexual Activity and that Dating Violence and Abuse are Part of Their Relationships
11. Successful Massachusetts Healthcare Reform Initiative Faces Rising Healthcare Costs in Year Two
Post Your Comments:
(Date:11/25/2015)... ... , ... Many people know of the common symptoms of low thyroid hormone ... But many people who find their cholesterol levels and weight are creeping up are ... if they don’t have any of the other symptoms. , Thyroid hormone plays a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Students and parents ... awarded to winners of the Create Real Impact awards. California Casualty is ... help stem the tide of distracted and reckless driving, the number one killer of ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. Seidel, DMD ... benefits of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology ... by a dentist in Gettysburg, PA . From routine visits to cosmetic ...
(Date:11/24/2015)... AZ (PRWEB) , ... November 24, 2015 , ... Young ... 2.0™ treatments from Dr. Angela Wolfman and Dr. Kedar S. Lele, who are ... for frenectomies, cavities and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort and ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... and variables that determine which patients are or are not eligible for bariatric surgery. ... a BMI over 40, are more than 100 pounds overweight, or have a BMI ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 Sectra (STO: ... has entered into a multi-year agreement to deploy ... investment will provide the Breast Center a future-proof platform ... (STO: SECT B) announces that Breast Center of ... deploy Breast Imaging PACS in its two freestanding imaging ...
(Date:11/24/2015)...   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart ... Doug Godshall is scheduled to present at ... on December 1, 2015 at 3:00 p.m. ET.  The ... New York . . ...
(Date:11/24/2015)... , November 24, 2015 ... of the University of Bern ... Nutrition of the Bern University Hospital "Inselspital" are proud ... develop a novel generation artificial pancreas. Combining a fully ... for diabetic patients with the unequalled accuracy of an ...
Breaking Medicine Technology: